INFORMATICS

DEVELOPMEN
T AGENCY

Digitally signed by
INFORMATICS
DEVELOPMENT AGENCY
Date: 2015.01.23 09:41:12
EET
Reason:
Location: Athens

: 56-46

/
&
/

: .
. : 19
. : 101 87
:,2132161327
FAX: 210 5237384
Email:ddy@yyka.gov.gr

, 22/1/2015
. . 1/...6055

:
.: 6

.:
9
1. , &

( )

29,, .. 10110
2. ...

( )
3.
/ & ( )
. /
4.
& ( )
/
( )
1

: 56-46
5.
( )
6. ...

384 ,11522
7.

39, 15123
( )
1.

37, 15180
2. /
(
)
3. /
153, 118 54
4. & &
/
( )
40, 101 82
5.
3, 10675 -
( )
6.
( )
134, 118 54 -
7.
( )
38, , .. 10678
8.
. 196 . . 11521
9. ..
. 127 . . 11521
10. ....
3-5, 15121 M
11.
.
/

..115 27 -
12.

39,
13.

205,
, .. 11853
14. ...
. 34, 16672

: 56-46
15. .

. .
& 1

1. .
2. .
3. .
4. . .
5. . . /
6. /

: 56-46

1.

19-26

27-49

50-59

60-64

65

, ,
(Td, Tdap) 2
, ,
(R)3
(VAR) 4
5
(HPV)6

Td Tdap 1 Td
10
1 2
2
1
3

(PCV13)7

(PPSV23)7

(MCV4)8
(HepA)9
(HepB)10
b (Hib)

1 2

1
2
3

11

1 3

( .

: 56-46

2.

V
CD4

( HIV)

<200 /l

,
,
,

>200 /l

, ,
2
(Td/Tdap)

, ,
3
(MMR)
4
(VAR)
5

6
(HPV)

7
(PCV13)

7
(PPSV23)
8
(MCV4)

1
Tdap

1-2

3 26

1

3
26

1
3 26

1-2
1

H (HepB)

A 1 Td Tdap Td 10-

H (HepA)

10

2
3

b
11
(Hib)

3
1

:
. .
.. , ,

: 56-46

1.

( 1, 2 )

[ : IIV3
(nactivated Influenza Vaccine (IIV3), TIV(Trivalent Inactivated
Vaccine)] 0,5 ml.
, IIV3 (nactivated Influenza Vaccine),
(. ).

2.

- (Td/TdaP)
, (TdapIPV).
1 Tdap , 27
36 , ,
Td Tdap.
11 Tdap
, Tdap
Td 10 .
Tdap
Td.
3-
,
Tdap. 2
4 6 12
. ( 3
) .
3. , , (MMR)
1970, .
1970 ,
MMR, ( )
, . .
MMR ( 28
) :
.
.
.
,
. ,
, . ,
MMR ,
.
1957:
2 MMR.

: 56-46

4.

5.

6.

(VAR)
, (
), 2 ,
.
:
,

.. .
, .. ,
, , ,
, ,
.

1
. 2
4-8 1 .
:
2 4
.

.

60
, .
60
, ( 2).
(HPV)
HPV 4(HPV4)
(HPV2) .
HPV . ,
.
,

.
HPV 18-26 ( )
31/12/2016.

: 56-46

7.

8.

(PCV13)

(PPSV23)
19- 64
: 1 PCV13 2
PPSV23.
PCV13 8 PPSV23
PPSV23 PCV13
1 .
2 PPSV23 5 PPSV23.
2 PPSV23 1 PCV13 1 2
PPSV23.
65
PCV13 PPSV23
PCV13 6-12
PPSV23.
PCV13 PPSV23 65
, PCV13 1 PPSV23.
PCV13 1 PPSV23 19-64
, PCV13 1 PPSV23 2
PPSV23 6-12 PCV13 5 PPSV23.
PCV13 PPSV23 19-64 ,
PPSV23 6-12 .
PCV13 1 PPSV23 19-64
, PPSV23, 5
PPSV23.
4 (MCV4)
4
:
1 MCV4 ,
,

( , )
. ,

Hajj.
/

HIV .

.



.
8

: 56-46

9.

(HepA)
:
.

.
.
.
.

, 60
. 2
2
.

10. (HepB)

.
:

.

.
.

.
.

.
.

, HIV, .
.
.
: 3
. 2 1 1 3
2 2 4 1.

40 mcg / ml , 3 ( 0, 1, 6 ), 4
(0, 1, 2, 6 ) .
11. b (Hib)
1

, Hib.
9

: 56-46

Hib
14
.

3 6 12
.
4 .
Hib HIV ,
.

.., , , ,
),
.

1.

, (>5 64 )

:
,
, ,
( IgG2)




,




HIV

2.

,
, HIV

10

: 56-46

( , )
( - )

Hajj

3. /

.

.
HIV (
AIDS.
,

.

4.

, ,

( )

, 60
. 2 2

5.

.

,

,
, HIV,
11

: 56-46

6.

60 .

:


(
).

( ).
.
.
-
, ,
() >40 kg/m2
>95
(.. Kawasaki,
)
Reye
<6
,
.
( (,
,
..).
(
)

(.. , )

11-12 ,

.

, ( ),
.

12